MBB Public Markets I LLC Takes $331,000 Position in The Cooper Companies, Inc. $COO

Key Points

• MBB Public Markets I LLC has initiated a position in The Cooper Companies, purchasing 3,920 shares valued at approximately $331,000 in the first quarter.
• Several research firms have reduced their price targets for Cooper Companies, with Robert W. Baird cutting their target from $97.00 to $85.00, reflecting a shift in analyst ratings for the stock.
• Insiders from Cooper Companies have been active in buying stock; EVP Brian G. Andrews acquired 1,525 shares worth $100,162, indicating confidence in the company's future.

MBB Public Markets I LLC bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,920 shares of the medical device company's stock, valued at approximately $331,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Shell Asset Management Co. lifted its holdings in Cooper Companies by 15.5% during the 4th quarter. Shell Asset Management Co. now owns 946 shares of the medical device company's stock worth $87,000 after buying an additional 127 shares in the last quarter. UMB Bank n.a. lifted its holdings in Cooper Companies by 16.7% during the 1st quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock worth $76,000 after buying an additional 129 shares in the last quarter. Horizon Investments LLC lifted its holdings in Cooper Companies by 5.0% during the 1st quarter. Horizon Investments LLC now owns 2,859 shares of the medical device company's stock worth $241,000 after buying an additional 136 shares in the last quarter. Axxcess Wealth Management LLC lifted its holdings in Cooper Companies by 1.9% during the 1st quarter. Axxcess Wealth Management LLC now owns 7,382 shares of the medical device company's stock worth $623,000 after buying an additional 140 shares in the last quarter. Finally, Mitchell & Pahl Private Wealth LLC lifted its holdings in Cooper Companies by 1.8% during the 1st quarter. Mitchell & Pahl Private Wealth LLC now owns 8,675 shares of the medical device company's stock worth $732,000 after buying an additional 157 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, CEO Albert G. White III acquired 10,000 shares of the stock in a transaction on Friday, September 5th. The shares were bought at an average cost of $68.39 per share, with a total value of $683,900.00. Following the transaction, the chief executive officer owned 226,151 shares of the company's stock, valued at approximately $15,466,466.89. This trade represents a 4.63% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Gerard H. Warner III acquired 1,450 shares of the stock in a transaction on Friday, September 5th. The shares were acquired at an average cost of $69.23 per share, for a total transaction of $100,383.50. Following the completion of the transaction, the chief operating officer directly owned 18,319 shares in the company, valued at $1,268,224.37. The trade was a 8.60% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders purchased 15,975 shares of company stock valued at $1,079,566. Company insiders own 1.98% of the company's stock.

Cooper Companies Stock Down 2.6%

NASDAQ:COO traded down $1.78 during midday trading on Friday, hitting $66.68. 3,147,814 shares of the company were exchanged, compared to its average volume of 3,235,975. The company has a fifty day simple moving average of $71.53 and a 200 day simple moving average of $76.00. The Cooper Companies, Inc. has a fifty-two week low of $61.78 and a fifty-two week high of $112.38. The company has a current ratio of 2.12, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The company has a market capitalization of $13.26 billion, a PE ratio of 32.85, a price-to-earnings-growth ratio of 1.80 and a beta of 0.97.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same period last year, the firm posted $0.96 EPS. Cooper Companies's revenue for the quarter was up 5.7% on a year-over-year basis. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Wall Street Zen lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Stifel Nicolaus dropped their price objective on shares of Cooper Companies from $90.00 to $85.00 and set a "buy" rating on the stock in a research report on Thursday, August 28th. BNP Paribas Exane raised shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price objective on the stock in a research report on Tuesday, July 22nd. UBS Group raised shares of Cooper Companies to a "buy" rating in a research report on Tuesday, June 17th. Finally, BNP Paribas raised shares of Cooper Companies from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $86.64.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.